17039014

Source:http://linkedlifedata.com/resource/pubmed/id/17039014

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0205179, umls-concept:C0278678, umls-concept:C0543467
pubmed:issue	5
pubmed:dateCreated	2006-10-13
pubmed:abstractText	Curative surgery in more advanced renal cell carcinoma is limited to solitary metastases or regional disease. Response to systemic immunotherapy continues to be reported; however, most responses are limited and not durable. Only randomized, prospective clinical trials will prove the efficacy of systemic therapy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9200621
pubmed:status	PubMed-not-MEDLINE
pubmed:month	Sep
pubmed:issn	0963-0643
pubmed:author	pubmed-author:ChanD YDY, pubmed-author:MarshallF FFF
pubmed:issnType	Print
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	369-73
pubmed:year	1998
pubmed:articleTitle	Surgery in advanced and metastatic renal cell carcinoma.
pubmed:affiliation	James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
pubmed:publicationType	Journal Article